Management of Children With or Exposed to HIV
Summary
- Current DHHS guidelines recommend that 4-week neonatal zidovudine can be used in infants of mothers who received standard combination ART during pregnancy with continuous virologic suppression and no maternal adherence concerns[DHHS Perinatal]
- Frequency of hematologic monitoring should be based on specific circumstances of each case[DHHS Perinatal]
- If anemia or other hematologic abnormalities occur, the decision to stop or continue prophylaxis should be individualized, and consultation with a pediatric HIV infection expert is recommended[DHHS Perinatal]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content